Diverse coding genes have been proposed to principally serve as biomarkers in strong association with GC stages and prognosis, including ERBB2, PTEN, PI3K/AKT/mTOR, TP53, HER2 and MYC (also named c-MYC) [7, 8]. The gene discussed is ERBB2; the disease is gastric cancer.